DMX-5804

N/A

Report date: 2025/01/26 16:35:14
NME

Base Information

Drug NameDMX-5804
Drug Alias NameMAP4 kinase 4 inhibitors (Domainex/NHLI)DMX-5804
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase kinase kinase kinase 4 inhibitors
TargetsMitogen-activated protein kinase kinase kinase kinase 4
Therapy Area/IndicationsMyocardial Reperfusion Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDomainex Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNational Heart & Lung InstituteDomainex Ltd
Inactive CompaniesN/A
Active IndicationsMyocardial Reperfusion Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A